Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
212 participants
INTERVENTIONAL
1999-09-30
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Integrated Mental Health Treatment & HIV Prevention for Court-Involved Youth
NCT01421485
Confidential Care and Adolescent HIV Testing
NCT06279949
HIV/STI Prevention Among Black Adolescents With Mental Illnesses (Project GOLD)
NCT03348813
HIV Prevention for Youth With Severe Mental Illness
NCT00496691
Intervention for Newly Diagnosed Youth With HIV
NCT00510237
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
13 session group intervention including sexual health information, affect management skills, cognitive monitoring, and communication skills training.
group intervention
13-session intervention
2
2 session group intervention including sexual health information training.
group intervention
2-session intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
group intervention
13-session intervention
group intervention
2-session intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Adolescent is developmentally delayed
* Adolescent is pregnant
* Adolescent has a history of sexual crime
13 Years
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rhode Island Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rhode Island Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Larry K. Brown, MD
Role: PRINCIPAL_INVESTIGATOR
Rhode Island Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rhode Island Hospital
Providence, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Brown LK, Nugent NR, Houck CD, Lescano CM, Whiteley LB, Barker D, Viau L, Zlotnick C. Safe Thinking and Affect Regulation (STAR): human immunodeficiency virus prevention in alternative/therapeutic schools. J Am Acad Child Adolesc Psychiatry. 2011 Oct;50(10):1065-74. doi: 10.1016/j.jaac.2011.06.018. Epub 2011 Aug 27.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.